Log in to save to my catalogue

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9ea24d8da194602b4d5516ec20b1b5d

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

About this item

Full title

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Diabetes, metabolic syndrome and obesity, 2024-01, Vol.17, p.1651-1666

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

One of the most critical functions of adipose tissue is the production of adipokines, ie, numerous active substances that regulate metabolism. One is the newly discovered FAM19A5, whose older name is TAFA-5.
The study aimed to review the literature on the FAM19A5 protein.
The review was conducted in December 2023 using the PubMed (Medline) se...

Alternative Titles

Full title

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f9ea24d8da194602b4d5516ec20b1b5d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9ea24d8da194602b4d5516ec20b1b5d

Other Identifiers

ISSN

1178-7007

E-ISSN

1178-7007

DOI

10.2147/DMSO.S460226

How to access this item